We are researching neuro-degenerative disorder focused on alpha synuclein. Our lead compound is Tomaraliman, a TLR2 agonist for Parkinsons' disease.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 20, Gwangnaru-Ro 6-Gil, Seongdong-Gu, #402 Eagle Town,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.neuramedy.com
- HQ
- Seoul, Seoul
Neuramedy Questions
Neuramedy's website is https://www.neuramedy.com
Neuramedy's LinkedIn profile is https://kr.linkedin.com/company/neuramedy
Neuramedy has
3 employees.
View email and phone details for 3
employees at Neuramedy.
Neuramedy's industry is
Biotechnology Research
Neuramedy's top competitors are
Johnson & Johnson,
Gc Genome,
Toolgen Inc.,
Prazer Therapeutics,
Thermo Fisher Scientific,
Medpace,
Almac Group,
Corestem Inc,
Novo Nordisk.
Neuramedy's categories are Biotechnology Research
Neuramedy's founding year is 2019
